Meiji Yang

Title: Meiji Yang: Innovator in Hepatoma-Derived Growth Factor-Like Proteins

Introduction

Meiji Yang is a notable inventor based in East Lyme, Connecticut. He has made significant contributions to the field of biotechnology, particularly in the development of novel proteins and their applications in medical science.

Latest Patents

Yang holds a patent for "Hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use." This invention provides HDGFX, a novel isolated polypeptide, along with a polynucleotide encoding HDGFX and antibodies that specifically bind to HDGFX or any of its derivatives, variants, mutants, or fragments. The invention also outlines methods for utilizing the HDGFX polypeptide, polynucleotide, and antibody in the detection and treatment of various pathological states, among other applications. He has 1 patent to his name.

Career Highlights

Meiji Yang is associated with Curagen Corporation, where he has been instrumental in advancing research and development in his field. His work has contributed to the understanding and potential treatment of diseases related to hepatoma-derived growth factors.

Collaborations

Yang has collaborated with notable colleagues, including Catherine Burgess and Richard August Shimkets, enhancing the research output and innovation at Curagen Corporation.

Conclusion

Meiji Yang's contributions to biotechnology, particularly through his patent on HDGFX, highlight his role as an innovator in the field. His work continues to pave the way for advancements in medical treatments and diagnostics.